« Back
Home /
Beta Amyloid (1-42) Aggregation Kit

Beta Amyloid (1-42) Aggregation Kit

Manufacturer	rPeptide
Category	Oncology Neuroscience Molecular Targets for Neuroscience Aging & Neurological Disorders Protein Aggregation, Clearance & Misfolding By Cell Type Adenocarcinoma Other Assays & Kits Other Kits
Type	Kit
Specific against	other
Format	Lyophilized powder
Amount	0.25 mg
Item no.	RPE-A-1170-025
Targets	APP
eClass 6.1	32161000
eClass 9.0	32161090
Available
Territory	This product is only available for customers from Austria or Switzerland!
Manufacturers Category	Human, Native, Mutant, Beta-Amyloid Peptides, Recombinant, E. Coli
Components	Contains components of a Thioflavin Assay; A-1167-025, 5Mm Tris, 10mM NaOH, 10X TBS pH 7.4, HPLC Water, 400uM Thioflavin
Storage	-20°C
Shipping	Ambient
Description (Long)	Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer's patients, is thought to be the cause of Alzheimer's Disease (AD). AD is the most common neurodegenerative disease and afflicts about 10% of the population over 60. Using a proprietary production technique that limits the peptide's conformational changes, rPeptide has produced an ammonium hydroxide beta amyloid counter-ion. rPeptide is proud to offer the beta amyloid aggregation kit. This kit allows researchers to monitor the properties of amyloid aggregation.
Physical State	White lyophilized powder

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.25 mg

available

Delivery expected until 6/6/2024